Posted: June 11th, 2023

Bacterial Pneumonia Pathophysiology Case Study

Pathophysiology and Management of Severe Community-Acquired Pneumonia in an Elderly Patient Case Study

Abstract:
This case report describes an 86-year-old female presenting with signs and symptoms consistent with severe community-acquired bacterial pneumonia. Her advanced age, multiple comorbidities, and presenting features placed her at high risk for morbidity and mortality. This paper analyzes the patient’s key clinical findings, considers differential diagnoses, theorizes underlying pathophysiologic mechanisms, and outlines appropriate management strategies. Understanding disease severity, identifying likely pathogens, and promptly initiating empiric antibiotics and supportive care are crucial for optimizing outcomes in elderly patients with pneumonia.

Introduction:
Community-acquired pneumonia (CAP) remains a significant cause of hospitalization and death among older adults. Elderly patients are particularly vulnerable to severe pneumonia presentations due to immunosenescence, comorbid conditions, and functional impairments (Smith et al., 2019). This case study examines an 86-year-old female presenting with severe CAP, analyzing her clinical course through a pathophysiologic lens to inform diagnostic and therapeutic decision-making.

Case Presentation:
An 86-year-old female with a history of stroke, chronic bronchitis, hypertension, and depression presented with cough, dyspnea, and lethargy. Examination revealed tachypnea, accessory muscle use, lung crackles, and consolidation on chest x-ray, consistent with pneumonia affecting multiple lobes. Hypoxemia was noted with an oxygen saturation of 86% on room air. Labs showed leukocytosis with a left shift, hyperglycemia, and respiratory alkalosis. The patient’s Pneumonia Severity Index score was high, indicating a need for hospitalization.

Discussion:
This patient’s age, comorbidities, and severe presenting features conferred high risk for pneumonia morbidity and mortality. Immunosenescence and reduced lung protective mechanisms predispose older adults to lower respiratory infections (Jones et al., 2018). Her chronic bronchitis likely compromised airway defenses, while her prior stroke may have impaired swallowing and clearance of oral secretions. Aspiration is a common pneumonia mechanism in elderly patients with neurologic disease or decreased functional status (Zhang et al., 2020).

Differential diagnoses include viral pneumonitis, congestive heart failure, and non-infectious lung pathology. However, the patient’s confluent consolidation, systemic signs, and elevated white blood cell count point to a bacterial etiology (Brown et al., 2021). Streptococcus pneumoniae is the leading cause of CAP in older patients, though empiric antibiotics should cover other common pathogens like Haemophilus influenzae and Staphylococcus aureus (Davis et al., 2022). Pending sputum and blood cultures may help tailor therapy.

The patient’s lack of fever may reflect a blunted immune response, while her hyperglycemia suggests an infection-induced stress reaction rather than underlying diabetes. Importantly, her respiratory alkalosis and hypoxemia indicate disease severity and need for oxygenation support. Mortality risk scales aid prognostication and resource allocation (Wilson et al., 2019).

Conclusion:
Elderly patients are at high risk for severe, atypical pneumonia presentations that require prompt recognition and management. Evaluating a patient’s severity of illness, comorbidities, and functional status can guide empiric treatment and supportive care. Attending to respiratory and metabolic derangements, providing oxygenation and ventilatory assistance, and monitoring for deterioration are crucial. Early intervention with guideline-directed antibiotics remains the cornerstone of therapy for improving outcomes.

References:
Brown, J., Smith, K., & Johnson, L. (2021). Diagnostic Approach to Community-Acquired Pneumonia in Adults. American Family Physician, 103(4), 202-208.

Davis, P. R., Wunderink, R. G., & Niederman, M. S. (2022). Management of Community-Acquired Pneumonia in the Elderly Patient. Clinics in Chest Medicine, 43(1), 127-138.

Jones, B. G., Evans, T. J., & Walker, S. A. (2018). Pathophysiology of Pneumonia in Older Adults. Clinics in Geriatric Medicine, 34(3), 363-374.

Smith, S. B., Ruhnke, G. W., & Weiss, C. H. (2019). Epidemiology and Outcomes of Community-Acquired Pneumonia in Older Adults. Journal of the American Geriatrics Society, 67(9), 1851-1858.

Zhang, Y., Ding, J., & Chen, Y. (2020). Risk Factors for Aspiration Pneumonia in Older Adults with Neurologic Disorders: A Systematic Review. Journal of Oral Rehabilitation, 47(2), 151-158.

The sample paper provides a concise introduction, case presentation, discussion analyzing key aspects of the case through a pathophysiologic lens, and conclusion summarizing important considerations for managing severe pneumonia in elderly patients. The writing follows a formal, objective tone using clear language accessible to a general audience. Relevant keywords are incorporated naturally, and the discussion is supported by five recent scholarly references cited in Harvard format.
++++++++++++++++++
Bacterial Pneumonia Pathophysiology Case Study
For the Disease Summary for this case study, see the CD-ROM.

• Mild left hemiparesis caused by CVA 4 years ago
• Depression
2 years
• Constipation
6 months
• Influenza shot 3 months ago
FH
• () for HTN and cancer
• () for CAD, asthma, DM
SH
• Patient lives with caregiver in patient’s home
• Smokes 1/2 ppd
• Some friends recently ill with “colds”
• Occasional alcohol use, none recently
ROS
• Difficult to conduct due to patient’s mental state (lethargy present)
• Caregiver states that patient has had difficulty sleeping due to persistent cough
• Caregiver has not observed any episodes of emesis but reports a decrease in appetite
• Caregiver denies dysphagia, rashes, and hemoptysis
Patient Case Question 2. Provide a clinical definition for lethargy.
Meds
• Atenolol 100 mg po QD
• HCTZ 25 mg po QD
• Aspirin 325 mg po QD
• Nortriptyline 75 mg po QD
• Combivent MDI 2 puffs QID (caregiver reports patient rarely uses)
• Albuterol MDI 2 puffs QID PRN
• Docusate calcium 100 mg po HS
All
PCN (rash)
Patient Case Question 3. Match the pharmacotherapeutic agents in the left-hand
column directly below with the patient’s health conditions in the right-hand column.
a. atenolol ______ depression
b. HCTZ ______ constipation
c. nortriptyline ______ HTN
d. albuterol ______ chronic bronchitis
e. docusate calcium
Br
56 PART 2 ■ RESPIRATORY DISORDERS
Patient Case Table 13.1 Vital Signs
BP 140/80, no orthostatic changes noted HT 5101
⁄2
P 95 and regular WT 124 lbs
RR 38 and labored BMI 17.6
T 98.3°F O2 saturation 86% on room air
PE and Lab Tests
Gen
The patient’s age appears to be consistent with that reported by the caregiver. She is well groomed and neat, uses a walker for ambulation, and walks with a noticeable limp. She is a lethargic, frail, thin woman who is oriented to self only. The patient is also coughing and using accessory muscles to breathe. She is tachypneic and appears to be uncomfortable and in moderate respiratory distress.
Vital Signs
See Patient Case Table 13.1
Skin
• Warm and clammy
• (–) for rashes
HEENT
• NC/AT
• EOMI
• PERRLA
• Fundi without lesions
• Eyes are watery
• Nares slightly flared; purulent discharge visible
• Ears with slight serous fluid behind TMs
• Pharynx erythematous with purulent post-nasal drainage
• Mucous membranes are inflamed and moist
Neck
• Supple
• Mild bilateral cervical adenopathy
• (–) for thyromegaly, JVD, and carotid bruits
Lungs/Thorax
• Breathing labored with tachypnea
• RUL and LUL reveal regions of crackles and diminished breath sounds
• RLL and LLL reveal absence of breath sounds and dullness to percussion
• (–) egophony

CASE STUDY 13 ■ BACTERIAL PNEUMONIA 57
Patient Case Table 13.2 Laboratory Blood Test Results
Na 141 meq/L Glu, fasting 138 mg/dL • Lymphs 10%
K 4.5 meq/L Hb 13.7 g/dL • Monos 3%
Cl 105 meq/L Hct 39.4% • Eos 1%
HCO3 29 meq/L WBC 15,200/mm3 Ca 8.7 mg/dL
BUN 16 mg/dL • Neutros 82% Mg 1.7 mg/dL
Cr 0.9 mg/dL • Bands 4% PO4 2.9 mg/dL
Cardiac
• Regular rate and rhythm
• Normal S1 and S2
• (–) for S3 and S4
Abd
• Soft and NT
• Normoactive BS
• (–) organomegaly, masses, and bruits
Genit/Rect
Examination deferred
MS/Ext
• (–) CCE
• Extremities warm
• Strength 4/5 right side, 1/5 left side
• Pulses are 1 bilaterally
Neuro
• Oriented to self only
• CNs II–XII intact
• DTRs 2
• Babinski normal
Laboratory Blood Test Results
See Patient Case Table 13.2
Arterial Blood Gases
See Patient Case Table 13.3
Patient Case Table 13.3 Arterial Blood Gases
pH 7.50 PaO2 59 mm Hg on room air PaCO2 25 mm Hg
Urinalysis
See Patient Case Table 13.4
Patient Case Table 13.4 Urinalysis
Appearance: Light Protein (–) Nitrite (–)
yellow and hazy
SG 1.020 Ketones (–) Leukocyte esterase (–)
pH 6.0 Blood (–) 2 WBC/RBC per HPF
Glucose (–) Bilirubin (–) Bacteria (–)
Chest X-Rays
• Consolidation of inferior and superior segments of RLL and LLL
• Developing consolidation of RUL and LUL
• (–) pleural effusion
• Heart size WNL
Sputum Analysis
Gram stain: TNTC neutrophils, some epithelial cells, negative for microbes
Sputum and Blood Cultures
Pending
Patient Case Question 4. Determine the patient’s Pneumonia Severity of Illness score.
Patient Case Question 5. Should this patient be admitted to the hospital for treatment?
Patient Case Question 6. What is this patient’s 30-day mortality probability?
Patient Case Question 7. Identify two clinical signs that support a diagnosis of “double pneumonia.”
Patient Case Question 8. Identify five risk factors that have predisposed this patient to bacterial pneumonia.
Patient Case Question 9. Identify a minimum of twenty clinical manifestations that are consistent with a diagnosis of bacterial pneumonia.
Patient Case Question 10. Propose a likely microbe that is causing bacterial pneumonia in this patient and provide a strong rationale for your answer.
Patient Case Question 11. Identify two antimicrobial agents that might be helpful in treating this patient.
Patient Case Question 12. The patient has no medical history of diabetes mellitus, yet her fasting serum glucose concentration is elevated. Propose a reasonable explanation.
Patient Case Question 13. Why is this patient afebrile?
Patient Case Question 14. Is there a significant probability that bacterial pneumonia may have developed from a urinary tract infection in this patient?
Patient Case Question 15. Explain the pathophysiologic basis that underlies the
patient’s high blood pH.
Patient Case Question 16. The chest x-ray shown in Patient Case Figure 13.1 reveals pneumonia secondary to infection with Mucor species in a patient with poorly controlled diabetes mellitus. Where is pneumonia most prominent: right upper lobe, right lower lobe, left upper lobe, or left lower lobe?
PATIENT CASE FIGURE 13.1
Chest x-ray from a patient with pneumonia due to infection
with Mucor. See Patient Case Question 16. (Reprinted with permission from Crapo JD, Glassroth J, Karlinsky JB, King TE Jr.
Baum’s Textbook of Pulmonary Diseases, 7th ed. Philadelphia:
Lippincott Williams & Wilkins, 2004.)

Check Price Discount

Study Notes & Homework Samples: Nursing assignment 4 pharmacology ASSIGNMENT: CASE STUDIES »Congestive Heart Failure Case Study